PACB

Pacific Biosciences of California, Inc.NASDAQHealthcare

$1.34-0.74%ClosedMarket Cap: $404.7M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-06	Barclays	—	Underweight	—
2025-12-15	Barclays	—	Equal Weight	—
2025-11-11	Piper Sandler	—	Neutral	—
2025-11-10	Stephens & Co.	—	Overweight	—
2025-08-11	Piper Sandler	—	Neutral	—
2025-06-25	Barclays	—	Equal Weight	—
2025-05-15	Stephens & Co.	—	Overweight	—
2025-05-15	Piper Sandler	—	Neutral	—
2025-04-10	Canaccord Genuity	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.48	$196.7M	4
Sun Dec 31	$-0.42	$223.8M	6
Mon Dec 31	$-0.35	$243.3M	4
Tue Dec 31	$-0.31	$269.9M	2